All articles by Hemanth Kumar

Top ten pharma companies in 2020

The global pharmaceutical industry is expected to witness positive growth as the top pharma companies are at forefront of the…
Filgotinib shows improvements in rheumatoid arthritis trial

A Phase III clinical trial led by a Stanford University School of Medicine investigator has demonstrated that Gilead Sciences’ filgotinib…
Tiziana reveals positive results for Milciclib in liver cancer trial

Tiziana Life Sciences has reported that Milciclib was well-tolerated in a Phase IIa clinical trial involving participants with advanced hepatocellular…
Intec’s late-stage Parkinson’s study fails to meet endpoints

Intec Pharma has reported top-line results from the Phase III ACCORDANCE clinical trial of its Accordion Pill-Carbidopa/Levodopa (AP-CD/LD) to treat…
Sandoz starts enrolment in biosimilar denosumab trial

Novartis subsidiary Sandoz has commenced patient enrolment in the Phase I/III ROSALIA clinical trial of its proposed biosimilar denosumab to…

Marker reports positive data from pancreatic cancer trial

Marker Therapeutics has reported positive interim results from an ongoing TACTOPS clinical trial evaluating Multi-Antigen Targeted (MultiTAA) T-cell therapy for…
Takeda’s study of subcutaneous vedolizumab meets primary goal

Takeda Pharmaceutical has reported that the VISIBLE 2 clinical trial of a subcutaneous (SC) formulation of vedolizumab met its primary…
Adaptimmune initiates first trial of new SPEAR T-cell asset

Adaptimmune Therapeutics has started the first clinical trial (SURPASS) of its next-generation SPEAR T-cell, ADP‑A2M4CD8, for the treatment of solid…
BMS, Ono, and Bayer partner to trial combination therapy for mCRC

Bristol-Myers Squibb (BMS), Ono Pharmaceutical, and Bayer have signed a clinical collaboration agreement to trial a combination therapy for the treatment…